References
- Gennaro, A. R. Remington's Pharmaceutical Sciences, 15th Ed.;Mach Publishing: Easton, PA, 1975; p 858.
- Clarke, E. G. C.; Moffat, A. C. Clarke's Isolation andIdentification of Drugs in Pharmaceuticals, Body Fluids, andPost-mortem Material, 2nd Ed.; Pharmaceutical Press: London,1986.
- Bell, C. E.; Somerill, A. R. Biochemistry Sect. J. 1966, 98, C 1.
- Imai, K. J. Chromatogr. 1975, 105, 135. https://doi.org/10.1016/S0021-9673(01)81097-9
- Sharma, C.; Mohanty, S.; Kumar, S.; Rao, N. G. Analyst 1996,121, 1963. https://doi.org/10.1039/an9962101963
- Lee, H. B.; Hong-you, R. L.; Fowlie, P. J. A. J. Assoc. Off. Anal.Chem. 1989, 72, 979.
- Zhu, A. Z.; Liu, J.; Fu, C. G. Fenxl. Ceshi, Xuebao 1997, 16,47.
- Tsuchiya, H.; Sato, M.; Kato, H.; Okubo, T.; Juncja, L. R.; Kim,M. J. Chromatogr. B Biomed. Appl. 1997, 703, 253. https://doi.org/10.1016/S0378-4347(97)00412-X
- Parsons, L. H.; Kerr, T. M.; Weiss, F. J. Chromatogr. B, Biomed.Appl. 1998, 709, 35. https://doi.org/10.1016/S0378-4347(98)00024-3
- Ricebery, L. J.; Vanuis, H. V.; Levin, L. Anal. Biochem. 1974, 60,551. https://doi.org/10.1016/0003-2697(74)90266-8
- Nozaki, O.; Iwaeda, T.; Kato, Y. J. Biolumin. Chemilumin. 1996,11, 309. https://doi.org/10.1002/(SICI)1099-1271(199611)11:6<309::AID-BIO424>3.0.CO;2-6
- Murayama, K.; Santa, T.; Imai, K. Chromatography 1998, 19,207.
- Li, J. G.; Lu, J. R. Fenxi. Huaxue 1997, 25, 314.
- Hu, S.; Li, P. B.; Cheng, J. K. Fenxi. Shiyanshi 1996, 15, 1.
- Kozminski, K. D.; Gutman, D. A.; Davila, V.; Sulzer, D.; Ewing,A. G. Anal. Chem. 1998, 70, 3123. https://doi.org/10.1021/ac980129f
- Aman, T.; Khan, I. U.; Aslam, N.; Ahmed, I. Anal. Lett. 1998, 31,1007. https://doi.org/10.1080/00032719808002838
- Biryuk, I. A.; Petrenko, V. V.; Zorya, B. P. Farm. Zh. (Kiw) 1992,2, 57.
- Mohamed, W. I.; Salem, F. B. Anal. Lett. 1984, 17, 191. https://doi.org/10.1080/00032718408065278
- Michotte, Y.; Moors, M.; Deleu, D.; Herregodts, P.; Ebinger, G. J. Pharm. Biomed. Anal. 1987, 5, 659. https://doi.org/10.1016/0731-7085(87)80078-X
- Sagar, A. K.; Smyth, M. R. J. Pharm. Biomed. Anal. 2000, 22,613. https://doi.org/10.1016/S0731-7085(00)00237-5
- Coello, J.; Maspoch, S.; Villegas, N. Talanta 2000, 53, 627. https://doi.org/10.1016/S0039-9140(00)00539-7
- Talebpour, Z.; Haghgoo, S.; Shamsipur, M. Anal. Chim. Acta2004, 506, 97. https://doi.org/10.1016/j.aca.2003.10.081
- Uslu, B.; Ozkan, S. A. Anal. Lett. 2002, 35, 303. https://doi.org/10.1081/AL-120002531
- Hasan, B. A.; Khalaf, K. D.; La Guardia, M. De Talanta 1995, 42,627. https://doi.org/10.1016/0039-9140(95)01464-M
Cited by
- Simultaneous Determination of Levodopa and Carbidopa in Levodopa-Carbidopa Tablets by ATR-FTIR Spectrometry vol.12, pp.6, 2007, https://doi.org/10.1080/10837450701481249
- Simultaneous kinetic spectrophotometric determination of Sn(II) and Co(II) by the calculation of the variation of ratio kinetic profiles vol.70, pp.6, 2015, https://doi.org/10.1134/S1061934815060106
- Bioinspired Artificial Melanosomes As Colorimetric Indicators of Oxygen Exposure vol.8, pp.7, 2016, https://doi.org/10.1021/acsami.5b11933
- Quantitative determination of L-DOPA in tablets by high performance thin layer chromatography vol.30, pp.12, 2007, https://doi.org/10.1002/jssc.200600533
- Simultaneous Spectrophotometric Determination of Levodopa and Carbidopa in Pharmaceutical Formulations and Water Samples by Using Mean Centering of Ratio Spectra and H-Point Standard Addition Methods vol.55, pp.6, 2007, https://doi.org/10.1248/cpb.55.865
- Simultaneous kinetic determination of levodopa and carbidopa by H-point standard addition method vol.44, pp.1, 2004, https://doi.org/10.1016/j.jpba.2007.02.020
- Recent development in derivative ultraviolet/visible absorption spectrophotometry: 2004–2008 : A review vol.635, pp.1, 2009, https://doi.org/10.1016/j.aca.2008.12.039
- The Determination of Parkinson’s Drugs in Human Urine by Applying Chemometric Methods vol.2019, pp.None, 2004, https://doi.org/10.1155/2019/7834362
- First- and Third-Derivative Spectrophotometry for Simultaneous Determination of Dexamethasone and Cytarabine in Pharmaceutical Formulations and Biological Fluids vol.86, pp.5, 2004, https://doi.org/10.1007/s10812-019-00904-3